Vancouver, British Columbia, Canada Centre for Drug Research and Development appeared to be the Corporate Investor, which was created in 2007. The company was established in North America in Canada. The main office of represented Corporate Investor is situated in the Vancouver.
The common things for fund are deals in the range of 100 thousands - 1 million dollars. The high activity for fund was in 2019. The fund is constantly included in less than 2 investment rounds annually.
For fund there is a match between the location of its establishment and the land of its numerous investments - Canada. Among the most successful fund investment fields, there are Biotechnology, Diabetes. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Zucara Therapeutics, Sitka Biopharma.
The typical case for the fund is to invest in rounds with 2 participants. Despite the Centre for Drug Research and Development, startups are often financed by Quark Venture, GF Securities. The meaningful sponsors for the fund in investment in the same round are Toronto Innovation Acceleration Partners, National Research Council of Canada Industrial Research Assistance Program. In the next rounds fund is usually obtained by The Leona M. and Harry B. Helmsley Charitable Trust, Canadian Glycomics Network.
Related Funds
| Fund Name | Location |
| 1st Source Bank | Indiana, South Bend, United States |
| Archangel Network of Funds | Canada, Kitchener, Ontario |
| Blue Haven Initiative | Cambridge, Massachusetts, United States |
| Boole | - |
| Countersoft | England, London, United Kingdom |
| Enfini Investments | Brazil, São Paulo, Sao Paulo |
| Geovation | England, London, United Kingdom |
| Healthcare Alpha Management | China, Shanghai |
| Hivers and Strivers | - |
| Jiayuan | Beijing, Beijing, China |
| KCK Global | Canada, Montréal, Quebec |
| KuGou | China, Guangdong Province, Huizhou |
| Neo Technology Ventures | Australia, New South Wales, North Sydney |
| ORIX Ventures | Connecticut, Hartford, United States |
| Sociedad de Inversiones Celta | - |
| Sumitomo Life Insurance Company | Japan, Osaka, Osaka Prefecture |
| Trigon TFI SA | Mazowieckie, Poland, Warszawa |
| Zhongji Holdings Groups | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Zucara Therapeutics | $525K | 03 Nov 2016 | British Columbia |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Zucara Therapeutics | $525K | 03 Nov 2016 | British Columbia |
